90 related articles for article (PubMed ID: 6232954)
21. A modified method for the identification of heterozygotes for Gaucher's disease using differential thermal inactivation.
Goodman C; O'Brien JS
Clin Genet; 1980 Sep; 18(3):226-31. PubMed ID: 6777098
[TBL] [Abstract][Full Text] [Related]
22. A case of type I Gaucher disease with cardiopulmonary amyloidosis and chitotriosidase deficiency.
Hrebícek M; Zeman J; Musilová J; Hodanová K; Renkema GH; Vepreková L; Ledvinová J; Hrebícek D; Sokolová J; Aerts JM; Elleder M
Virchows Arch; 1996 Nov; 429(4-5):305-9. PubMed ID: 8972767
[TBL] [Abstract][Full Text] [Related]
23. Human acid beta-glucosidase: affinity purification of the normal placental and Gaucher disease splenic enzymes on N-alkyl-deoxynojirimycin-sepharose.
Osiecki-Newman KM; Fabbro D; Dinur T; Boas S; Gatt S; Legler G; Desnick RJ; Grabowski GA
Enzyme; 1986; 35(3):147-53. PubMed ID: 2944742
[TBL] [Abstract][Full Text] [Related]
24. Properties of acid ceramidase from human spleen.
Al BJ; Tiffany CW; Gomes de Mesquita DS; Moser HW; Tager JM; Schram AW
Biochim Biophys Acta; 1989 Aug; 1004(2):245-51. PubMed ID: 2526656
[TBL] [Abstract][Full Text] [Related]
25. Molecular weight of human brain neutral sphingomyelinase determined in situ by the radiation inactivation method.
Levade T; Potier M; Salvayre R; Douste-Blazy L
J Neurochem; 1985 Aug; 45(2):630-2. PubMed ID: 2989432
[TBL] [Abstract][Full Text] [Related]
26. Adult Gaucher's disease: kindred studies and demonstration of a deficiency of acid beta-glucosidase in cultured fibroblasts.
Ho MW; Seck J; Schmidt D; Veath ML; Johnson W; Brady RO; O'Brien JS
Am J Hum Genet; 1972 Jan; 24(1):37-45. PubMed ID: 5012691
[No Abstract] [Full Text] [Related]
27. Qualitative characteristics of the beta-glucosidase isozymes.
Choy FY; Davidson RG
Prog Clin Biol Res; 1982; 95():415-41. PubMed ID: 6812079
[No Abstract] [Full Text] [Related]
28. Soluble and membranous neutral beta-glucosidases.
Ben-Yoseph Y; Nadler HL
Prog Clin Biol Res; 1982; 95():465-80. PubMed ID: 6812082
[TBL] [Abstract][Full Text] [Related]
29. Immunological recognition of modifications on functionally related proteins.
Knecht DA; Mierendorf RC; Dimond RL
Methods Enzymol; 1983; 98():159-66. PubMed ID: 6199650
[No Abstract] [Full Text] [Related]
30. Acid lability of the mutated glucosylceramide-beta-glucosidase in a lymphoid cell line from type 2 Gaucher disease.
Maret A; Salvayre R; Troly M; Douste-Blazy L
Enzyme; 1990; 43(2):99-106. PubMed ID: 2124538
[TBL] [Abstract][Full Text] [Related]
31. Glyconamides as inhibitors of human beta-glucosidases and beta-galactosidases.
Chiao YB; Moffitt K; Smallwood Y; Glew RH; Naoi M; Lee YC
Arch Biochem Biophys; 1979 Jan; 192(1):1-9. PubMed ID: 107857
[No Abstract] [Full Text] [Related]
32. Deficiency of glucosylsphingosine: beta-glucosidase in Gaucher disease.
Raghavan SS; Mumford RA; Kanfer JN
Biochem Biophys Res Commun; 1973 Sep; 54(1):256-63. PubMed ID: 4741565
[No Abstract] [Full Text] [Related]
33. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
Owada M; Sakiyama T; Kitagawa T
Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
[TBL] [Abstract][Full Text] [Related]
34. The cohydrolases in human spleen that stimulate glucosyl ceramide beta-glucosidase.
Iyer SS; Berent SL; Radin NS
Biochim Biophys Acta; 1983 Oct; 748(1):1-7. PubMed ID: 6615847
[TBL] [Abstract][Full Text] [Related]
35. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of beta-glucosidases of animal tissues.
Radin NS
Adv Exp Med Biol; 1978; 101():589-600. PubMed ID: 96666
[No Abstract] [Full Text] [Related]
37. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
Gatt S; Dinur T; Desnick RJ
Prog Clin Biol Res; 1982; 95():315-31. PubMed ID: 6812076
[No Abstract] [Full Text] [Related]
38. Characterization of beta-glucosidase as a peripheral enzyme of lysosomal membranes from mouse liver and purification.
Imai K
J Biochem; 1985 Nov; 98(5):1405-16. PubMed ID: 3936851
[TBL] [Abstract][Full Text] [Related]
39. Isozymes of beta-glucosidase: determination of Gaucher's disease phenotypes.
Ginns EI; Erickson A; Tegelaers FP; Barneveld R; Reuser AJ; Brady RO; Tager JM; Barranger JA
Isozymes Curr Top Biol Med Res; 1983; 11():83-93. PubMed ID: 6417048
[No Abstract] [Full Text] [Related]
40. Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting.
Fabbro D; Desnick RJ; Grabowski GA
Am J Hum Genet; 1987 Jan; 40(1):15-31. PubMed ID: 3812484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
